Literature DB >> 20845049

Cerebellopontine angle tumors causing hemifacial spasm: types, incidence, and mechanism in nine reported cases and literature review.

Seung Hwan Lee1, Bong Arm Rhee, Seok Keun Choi, Jun Seok Koh, Young Jin Lim.   

Abstract

OBJECTIVE: Although hemifacial spasm is usually caused by vascular compression around the root exit zone of the facial nerve, it is sometimes brought on by a cerebellopontine angle tumor. We reviewed and analyzed data from past experience with hemifacial spasm induced by cerebellopontine angle tumors.
METHODS: Nine patients of a total 2,050, who had presented with hemifacial spasms associated with cerebellopontine angle tumors between 1986 and 2009, were reviewed.
RESULTS: Two vestibular schwannomas, five meningiomas, and two epidermoid tumors were included in this study. Hemifacial spasm occurred on the same side of the lesion in eight patients whereas it occurred on the opposite side of the lesion in one patient. With respect to the pathogenesis of hemifacial spasms, offending vessels were found in six patients, tumor encasement of the facial nerve in one patient, hypervascular tumor compression of the facial nerve without offending vessels in one patient, and a huge tumor compressing the brain stem and, thus, contralateral facial nerve compression in one patient. Hemifacial spasm was resolved in seven patients, whereas in two patients with a vestibular schwannoma and an epidermoid tumor, it improved transiently and then recurred in a month.
CONCLUSIONS: Each type of tumor had different characteristics with respect to the induction of hemifacial spasm; therefore, it is suggested that neurosurgeons, who are planning surgeries both for the purposes of relieving hemifacial spasm and removal of cerebellopontine angle tumor, should thoroughly prepare appropriate approaches and specific dissecting strategies according to each causative lesion.

Entities:  

Mesh:

Year:  2010        PMID: 20845049     DOI: 10.1007/s00701-010-0796-1

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  9 in total

1.  Management of symptomatic hemifacial spasm or trigeminal neuralgia.

Authors:  Ming-Xing Liu; Jun Zhong; Ning-Ning Dou; Lei Xia; Bin Li; Shi-Ting Li
Journal:  Neurosurg Rev       Date:  2016-02-15       Impact factor: 3.042

Review 2.  Immediate disappearance of hemifacial spasm after partial removal of ponto-medullary junction anaplastic astrocytoma: case report.

Authors:  Melina Castiglione; Morgan Broggi; Roberto Cordella; Francesco Acerbi; Paolo Ferroli
Journal:  Neurosurg Rev       Date:  2014-11-11       Impact factor: 3.042

3.  Developmental venous anomaly responsible for hemifacial spasm.

Authors:  R Chiaramonte; M Bonfiglio; A D'Amore; I Chiaramonte
Journal:  Neuroradiol J       Date:  2013-05-10

4.  Evaluation of Cerebellopontine Angle Epidermoid Presenting with Cranial Nerve Deficit: A Surgical Perspective.

Authors:  Rahul Singh; Ravi Shankar Prasad; Ashvamedh Singh
Journal:  Asian J Neurosurg       Date:  2020-08-28

5.  Cerebellopontine angle epidermoid cysts: clinical presentations and surgical outcome.

Authors:  Mitsuhiro Hasegawa; Mohsen Nouri; Shinya Nagahisa; Koichiro Yoshida; Kazuhide Adachi; Joji Inamasu; Yuichi Hirose; Hironori Fujisawa
Journal:  Neurosurg Rev       Date:  2015-11-14       Impact factor: 3.042

6.  Hemifacial spasm developed after contralateral vertebral artery ligation.

Authors:  Hyuk Jai Choi; Sung Ho Lee; Seok Keun Choi; Bong Arm Rhee
Journal:  J Korean Neurosurg Soc       Date:  2012-01-31

7.  Two Cases of Secondary Hemifacial Spasm: Pathophysiology and Management.

Authors:  Frederick A Zeiler; Anthony M Kaufmann
Journal:  J Mov Disord       Date:  2015-05-31

Review 8.  Hemifacial spasm and neurovascular compression.

Authors:  Alex Y Lu; Jacky T Yeung; Jason L Gerrard; Elias M Michaelides; Raymond F Sekula; Ketan R Bulsara
Journal:  ScientificWorldJournal       Date:  2014-10-28

9.  Commentary.

Authors:  Hao Yin
Journal:  J Neurosci Rural Pract       Date:  2012-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.